Compugen Ltd
TASE:CGEN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Compugen Ltd
TASE:CGEN
|
IL |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
XBER:MUV2
|
DE |
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
CA |
|
Elicio Therapeutics Inc
NASDAQ:ELTX
|
US |
|
Illumina Inc
NASDAQ:ILMN
|
US |
|
F
|
Fresenius Medical Care AG & Co KGaA
F:FME
|
DE |
|
V
|
Vita 34 AG
LSE:0NLV
|
DE |
|
S
|
Sharc International Systems Inc
OTC:INTWF
|
CA |
|
Saturn Oil & Gas Inc
XTSX:SOIL
|
CA |
Wall St Price Targets
CGEN Price Targets Summary
Compugen Ltd
According to Wall Street analysts, the average 1-year price target for CGEN is 1 383.05 ILS with a low forecast of 1 190.86 ILS and a high forecast of 1 857.04 ILS.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CGEN's stock price target?
Price Target
1 383.05
ILS
According to Wall Street analysts, the average 1-year price target for CGEN is 1 383.05 ILS with a low forecast of 1 190.86 ILS and a high forecast of 1 857.04 ILS.
What is the Revenue forecast for Compugen Ltd?
Projected CAGR
11%
Over the last 1 year, the compound annual growth rate for Revenue has been 161%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for Compugen Ltd?
Projected CAGR
12%
Over the last 1 year, the compound annual growth rate for Gross Profit has been 219%. The projected CAGR for the next 8 years is 12%.
What is the Operating Income forecast for Compugen Ltd?
Projected CAGR
8%
The compound annual growth rate for Operating Income over the next 8 years is 8%.
What is the Net Income forecast for Compugen Ltd?
Projected CAGR
8%
The compound annual growth rate for Net Income over the next 8 years is 8%.
